Ellevest, Inc. Ardelyx, Inc. Transaction History
Ellevest, Inc.
- $608 Million
- Q2 2025
Shares
2 transactions
Others Institutions Holding ARDX
# of Institutions
231Shares Held
170MCall Options Held
517KPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA18.4MShares$103 Million0.0% of portfolio
-
Black Rock Inc. New York, NY17.6MShares$98.1 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X015.1MShares$84.2 Million0.03% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny11.7MShares$65.2 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C311.5MShares$64 Million0.06% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $864M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...